आइसलैंड -
आइसलैंडी -
LYFJASTOFNUN (Icelandic Medicines Agency)
ciflox (ciproxin-hydrocortison) eyrnadropar, dreifa 2 mg + 10 mg/ml
novartis healthcare a/s - ciprofloxacinum hýdróklóríð; hydrocortisonum inn - eyrnadropar, dreifa - 2 mg + 10 mg/ml
आइसलैंड -
आइसलैंडी -
LYFJASTOFNUN (Icelandic Medicines Agency)
lidbree leghlaup 42 mg/ml
gedeon richter plc.* - lidocainum inn - leghlaup - 42 mg/ml
आइसलैंड -
आइसलैंडी -
LYFJASTOFNUN (Icelandic Medicines Agency)
maxidex augndropar, dreifa 1 mg/ml
novartis healthcare a/s - dexamethasonum fosfat - augndropar, dreifa - 1 mg/ml
आइसलैंड -
आइसलैंडी -
LYFJASTOFNUN (Icelandic Medicines Agency)
maxitrol augndropar, dreifa
novartis healthcare a/s - neomycinum súlfat; polymyxinum b súlfat; dexamethasonum fosfat - augndropar, dreifa
आइसलैंड -
आइसलैंडी -
LYFJASTOFNUN (Icelandic Medicines Agency)
oracea hart hylki með breyttan losunarhraða 40 mg
galderma nordic ab - doxycyclinum inn - hart hylki með breyttan losunarhraða - 40 mg
आइसलैंड -
आइसलैंडी -
LYFJASTOFNUN (Icelandic Medicines Agency)
tobradex augndropar, dreifa
novartis healthcare a/s - dexamethasonum fosfat; tobramycinum inn - augndropar, dreifa
यूरोपीय संघ -
आइसलैंडी -
EMA (European Medicines Agency)
dabigatran etexilate accord
accord healthcare s.l.u. - dabigatran etexilate mesilate - venous thromboembolism; arthroplasty, replacement - blóðþurrðandi lyf - prevention of venous thromboembolic events.
यूरोपीय संघ -
आइसलैंडी -
EMA (European Medicines Agency)
pombiliti
amicus therapeutics europe limited - cipaglucosidase alfa - glycogen geymsluskammt tegund ii - Önnur meltingarvegi og efnaskipti vörur, - pombiliti (cipaglucosidase alfa) is a long-term enzyme replacement therapy used in combination with the enzyme stabiliser miglustat for the treatment of adults with late-onset pompe disease (acid α-glucosidase [gaa] deficiency).
यूरोपीय संघ -
आइसलैंडी -
EMA (European Medicines Agency)
opfolda
amicus therapeutics europe limited - miglustat - glycogen geymsluskammt tegund ii - Önnur meltingarfæri og umbrotsefni - opfolda (miglustat) is an enzyme stabiliser of cipaglucosidase alfa long-term enzyme replacement therapy in adults with late-onset pompe disease (acid α- glucosidase [gaa] deficiency).